Literature DB >> 16342205

Alternative splicing in protein associated with Myc (Pam) influences its binding to c-Myc.

Túlio M Santos1, Sangyeul Han, Mark Bowser, Karen Sazani, Roberta L Beauchamp, Vanishree Murthy, Pradeep G Bhide, Vijaya Ramesh.   

Abstract

We recently identified Pam (for protein associated with c-Myc), as a binding partner for the tuberous sclerosis complex (TSC) protein tuberin in brain. The highly conserved Pam homologs in Drosophila and C. elegans are neuron-specific proteins that regulate synaptic growth. The Pam gene contains 83 exons and encodes a 4,641-amino-acid polypeptide with a predicted molecular weight of approximately 510 kDa. In a previous study, we demonstrated that Pam is expressed as two forms, approximately 450 kDa in rat embryonic and a approximately 350 kDa in rat adult brain. Here we have extended that work to show the approximately 450 kDa form is expressed in rat embryonic kidney, heart, and lung and in rat cell lines, and the approximately 350 kDa form is expressed in adult rat tissues as well as in human and mouse brain and human and mouse cell lines. To understand the size difference, we investigated alternative splicing of Pam in brain and detected six isoforms in the Myc-binding region resulting from splicing of exon 53, and three new exons, 52A, 56, and 56A. We also demonstrate that the presence of exon 52A in Pam significantly enhances binding to Myc, suggesting functional importance of this alternative splicing. The presence of Pam in many cellular compartments, its spliced variants, as well as its multiple binding partners, including tuberin, make it a complex, yet intriguing protein in the nervous system. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16342205     DOI: 10.1002/jnr.20723

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  8 in total

1.  The requirement for Phr1 in CNS axon tract formation reveals the corticostriatal boundary as a choice point for cortical axons.

Authors:  A Joseph Bloom; Bradley R Miller; Joshua R Sanes; Aaron DiAntonio
Journal:  Genes Dev       Date:  2007-09-27       Impact factor: 11.361

2.  Characterization of zebrafish Esrom (Myc-binding protein 2) RCC1-like domain splice variants.

Authors:  Hui Wang
Journal:  Mol Cell Biochem       Date:  2010-02-09       Impact factor: 3.396

3.  The RCC1 domain of protein associated with Myc (PAM) interacts with and regulates KCC2.

Authors:  Nicole Garbarini; Eric Delpire
Journal:  Cell Physiol Biochem       Date:  2008-07-25

4.  Pam (Protein associated with Myc) functions as an E3 ubiquitin ligase and regulates TSC/mTOR signaling.

Authors:  Sangyeul Han; Rochelle M Witt; Túlio M Santos; Carolyn Polizzano; Bernardo L Sabatini; Vijaya Ramesh
Journal:  Cell Signal       Date:  2008-02-01       Impact factor: 4.315

5.  The E3 ubiquitin ligase protein associated with Myc (Pam) regulates mammalian/mechanistic target of rapamycin complex 1 (mTORC1) signaling in vivo through N- and C-terminal domains.

Authors:  Sangyeul Han; Sun Kim; Samira Bahl; Lin Li; Clara F Burande; Nicole Smith; Marianne James; Roberta L Beauchamp; Pradeep Bhide; Aaron DiAntonio; Vijaya Ramesh
Journal:  J Biol Chem       Date:  2012-07-13       Impact factor: 5.157

6.  The Nesprin family member ANC-1 regulates synapse formation and axon termination by functioning in a pathway with RPM-1 and β-Catenin.

Authors:  Erik D Tulgren; Shane M Turgeon; Karla J Opperman; Brock Grill
Journal:  PLoS Genet       Date:  2014-07-10       Impact factor: 5.917

Review 7.  The PHR proteins: intracellular signaling hubs in neuronal development and axon degeneration.

Authors:  Brock Grill; Rodney K Murphey; Melissa A Borgen
Journal:  Neural Dev       Date:  2016-03-23       Impact factor: 3.842

8.  The CARM1-p300-c-Myc-Max (CPCM) transcriptional complex regulates the expression of CUL4A/4B and affects the stability of CRL4 E3 ligases in colorectal cancer.

Authors:  Wenzhu Lu; Chunmei Yang; Hongbo He; Hong Liu
Journal:  Int J Biol Sci       Date:  2020-02-04       Impact factor: 6.580

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.